glp 1 logo The Most Trusted Source for GLP-1 Insights and Savings Understanding GLP-1: What You Need – GLP Diet App Launches Personalized

Salernos treatments aim to provide effective relief and sustainable health improvements for patients diagnosed with Cushings Syndrome

NICE has published guidance on pharmacological interventions for weight management, including NICE guideline CG189 (Obesity: identification, assessment and management) and a technology appraisal supporting the use of semaglutide (Wegovy) for adults with a BMI of 35 kg/m or above (or 3034.9 kg/m in certain circumstances) alongside a specialist weight management service

To learn more about how MOTS-C can help you, contact us to schedule a consultation

Although experience with GLP-1 agonists in patients with obesity and inflammatory skin diseases is currently scarce, the promising results reported suggest they may offer a useful tool for managing obesity

Indinavir (Crixivan) Vitamin C can modestly reduce indinavir levels